Bose, Prithviraj <br/><br/>
Pathways and mechanisms of venetoclax resistance.  [electronic resource] 

 -  Leukemia & lymphoma  09 2017 
 - 1-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2017.1283032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Apoptosis--drug effects<br/>Biomimetics<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Clinical Trials as Topic<br/>Drug Discovery<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors<br/>Neoplasms--drug therapy<br/>Peptide Fragments--pharmacology<br/>Proto-Oncogene Proteins--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Sulfonamides--pharmacology<br/>bcl-X Protein--antagonists & inhibitors